We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Imaginatik | LSE:IMTK | London | Ordinary Share | GB00BFMDJC60 | ORD 0.002P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.945 | 0.92 | 0.97 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/1/2011 13:48 | I bought a few today | solarno lopez | |
10/1/2011 16:20 | large trades today. Hopefully MT selling | asparks | |
30/12/2010 11:02 | MT, sell your shares and leave please. You will end up ruining this company otherwise. No more General Meeting Requisitions please. | asparks | |
22/12/2010 12:50 | my broker reckons it could be a buy but same supposition | solarno lopez | |
22/12/2010 12:02 | somone sold 1.5 Mill for 1.6p and the price goes up....something's afoot | asparks | |
22/12/2010 11:16 | That makes a lot of sense ASPARKS its a nice compromise but the directors will have to support a rights issue unless they can get outside backing | solarno lopez | |
22/12/2010 09:48 | I reckon the current directors and major shareholders whould buy MT shares even if for a large premium | asparks | |
22/12/2010 09:43 | Mark - please just sell your shares and leave this company alone. Seems you are not helping the recovery by your antics | asparks | |
22/12/2010 09:40 | think is is bitter | asparks | |
22/12/2010 08:07 | Mark Turrell has requested another EGM .....bear in mind that all these meetings cost, not just in print and postage but legal fees as well.....one sure way to bust the company...WELL DONE MARK....if you can't beat em just keep calling meetings and bust the company..... | solarno lopez | |
16/12/2010 09:33 | Time to report thehub ... I love how rampers miss out the word "speculative" when ramping dud stock. | ihavenoclue | |
16/12/2010 08:44 | The big problem here is the company will run out of cash therefore a fund raising must be in the offing and at what price | solarno lopez | |
16/12/2010 08:39 | What has INDITHERM go to to do with this thread.....NOTHING | solarno lopez | |
16/12/2010 08:33 | Any small investor who hasn't realised it already will, on reading today's accounts, realise that the company was heading towards the rocks at full throttle under the stewardship of the previous CEO. The company claim that none of his senior colleagues want him back. I believe that assertion, and no way would I vote for the return of MT. It seems to me that Imaginatik is badly in need of refinancing and provided the management conflict and boardroom mess hasn't damaged the company's reputation irrevocably, we may yet see it develop into a successful USA-focused innovation service company. Having a CEO who tempers optimism with reality is certainly an improvement on the last one, and we may now be able be able to attract long-term investment in what is still an exciting growth segment. | caradog | |
07/12/2010 10:13 | I need 5p PS to BE. If it even gets near that, I'm out. | asparks | |
06/12/2010 14:21 | looking good.......not | asparks | |
15/11/2010 15:40 | Well, I would certainly vote for the resolutions - but then I'm no longer a holder here. | someuwin | |
15/11/2010 15:33 | its getting interesting: IDMIMTK RNS Number : 2050W Imaginatik PLC 15 November 2010 ? 15 November 2010 Imaginatik plc ("Imaginatik" or the "Company") Requisition of General Meeting Imaginatik plc announces that it has received a requisition (the "Requisition") for a General Meeting ("GM") of the Company from Mark Turrell who is the holder of ordinary shares of 0.0625 pence in the Company representing more than 35 per cent. of the Company's issued share capital. The Requisition requires the Directors to convene a GM of the Company to consider the following resolutions as ordinary resolutions: 1. THAT, Mr Matt J Cooper be and is hereby removed from office as a director of the Company with immediate effect. 2. THAT, Mr Shawn K Taylor be and is hereby removed from office as a director of the Company with immediate effect. 3. THAT, Mr Mark Turrell be and is hereby appointed as a director of the Company with immediate effect. The Company will, within 21 days of 12 November 2010, prepare a response to the Requisition and send a circular to shareholders convening the requisite GM, as required by section 303 of the Companies Act 2006, which must be held within 28 days of the date of despatch of the circular. The Company is taking legal advice as to the contents and validity of the Requisition. Furthermore, the Company is confident that if the resolutions set out above are indeed required to be put to shareholders at a GM that they will be defeated and, therefore it regards the Requisition as an unnecessary distraction and a waste of the Company's resources. | asparks | |
11/10/2010 17:07 | Imaginatik (IMTK, 2.625p, £5.58m), the provider of idea management software has extended its contract with Pfizer. This contract extension builds on an existing annual agreement for Open Innovation with Pfizer and increases the annual recurring license fee. The share price has risen by 50% since our recent speculative buy recommendation. We are therefore encouraged to reduce our recommendation to a HOLD. (Amisha Chohan) | andrbea | |
11/10/2010 10:18 | New head of research is a former Pfizer man, Pfizer main shareholder, and now extension of Pfizer licence at a higher price. I assume from all this that Pfizer wanted Mark Turrell out, for whatever reason. But that's just a guess. I'm just a shareholder, so what do I know? | caradog | |
11/10/2010 08:02 | 28% rise Imaginatik plc (AIM: IMTK.L), a leading provider of idea management software and innovation consultancy, is pleased to announce that it has signed a contract extension with Pfizer, Inc., one of the world's leading pharmaceutical companies. This contract extension builds on an existing annual agreement for Open Innovation with Pfizer and increases the annual recurring license fee. | andrbea | |
04/10/2010 12:53 | 'Imaginatik plc (AIM:IMTK), a leading provider of idea management software and innovation consultancy, announces that on 30 September 2010, the remuneration committee of the Board approved the issue of share options to all employees, including directors, and also approved the re-basing of the exercise price of all subsisting share options in issue at that date, to 2.55p per share. This provides both the senior management team and employees an appropriate and effective incentive for the future.' Hands up anyone who thinks that was done to incentivise the employees rather than screw Mark Turrell. Disgraceful, if predictable, treatment of existing shareholders, I say. | supernumerary |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions